Angiotensin Receptor Neprilysin Inhibition and Associated Outcomes by Race and Ethnicity in Patients With Heart Failure With Reduced Ejection Fraction: Data From CHAMP-HF

By rosaguerrero • June 21, 2022

Chapman B, Hellkamp AS, Thomas LE, Albert NM, Butler J, Patterson JH, Hernandez AF, Williams FB, Shen X, Spertus JA, Fonarow GC, DeVore AD. Angiotensin Receptor Neprilysin Inhibition and Associated Outcomes by Race and Ethnicity in Patients With Heart Failure With Reduced Ejection Fraction: Data From CHAMP-HF. J Am Heart Assoc. 2022 Jun 20;11(12):e022889. doi: 10.1161/JAHA.121.022889. Epub ahead of print. PMID: 35722989; PMCID: PMC9238653.

Tags: angiotensin receptor neprilysin inhibitor, Cardiology/Epi, heart failure, population groups, Publications, registries, sacubitril/valsartan

Treated HIV infection is not associated with carotid vascular inflammation or plaque progression as assessed by dynamic contrast magnetic resonance imaging

Shakil S, Chen D, Isquith D, Sapp J, Pommier I, Chu B, Guo Y, Canton G, Balu N, Yuan C, Hatsukami T, Maynard C, Zhao[...]

Differences in Ambulatory Care Outcomes Between Trainees and Faculty: A Multi-center Study

Graham KL, Amat M, Norian E, Li J, Weintraub J, Shaik A, Boggan JC, Davy J, Lyons A, Semour L, Rogers R, Davis RB. Differences[...]

Comparative assessment of CAC and SIS plaque burden categories via AI-guided quantitative CT analysis

Iskander B, Ichikawa K, Punnanithinont N, Kambalapalli S, Kinninger A, Krishnan S, Lakshmanan S, Roy S, Budoff MJ. Comparative assessment of CAC and SIS plaque[...]